Cargando…
Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease
BACKGROUND & AIMS: The value of liver stiffness measurement (LSM) by transient elastography (TE) for non‐invasive fibrosis staging and disease monitoring has not been established in patients with Wilson disease (WD). METHODS: Liver stiffness measurement by TE and non‐invasive fibrosis scores (AP...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187206/ https://www.ncbi.nlm.nih.gov/pubmed/31898387 http://dx.doi.org/10.1111/liv.14368 |
_version_ | 1783527125092925440 |
---|---|
author | Paternostro, Rafael Pfeiffenberger, Jan Ferenci, Peter Stättermayer, Albert F. Stauber, Rudolf E. Wrba, Fritz Longerich, Thomas Lackner, Karoline Trauner, Michael Ferlitsch, Arnulf Reiberger, Thomas Weiss, Karl Heinz |
author_facet | Paternostro, Rafael Pfeiffenberger, Jan Ferenci, Peter Stättermayer, Albert F. Stauber, Rudolf E. Wrba, Fritz Longerich, Thomas Lackner, Karoline Trauner, Michael Ferlitsch, Arnulf Reiberger, Thomas Weiss, Karl Heinz |
author_sort | Paternostro, Rafael |
collection | PubMed |
description | BACKGROUND & AIMS: The value of liver stiffness measurement (LSM) by transient elastography (TE) for non‐invasive fibrosis staging and disease monitoring has not been established in patients with Wilson disease (WD). METHODS: Liver stiffness measurement by TE and non‐invasive fibrosis scores (APRI, FIB‐4) were analysed from 188 WD patients with liver biopsy (LBX). Longitudinal LSM was performed in 128 (68.1%) patients. RESULTS: One hundred and eighty‐eight patients (mean age: 35 ± 14 years, 54.8% women; 27.1% with histological cirrhosis) were studied. Forty‐four[23.4%] patients were recently diagnosed with WD, while 144[76.6%] were previously diagnosed (>1 year between LBX and LSM). Overall, LSM (11.3 vs 6.1 kPa, P < .001), APRI (0.72 vs 0.38, P < .001) and FIB‐4 (1.54 vs 0.89, P < .001) were higher in cirrhotic than in non‐cirrhotic patients. This was even more pronounced in recently diagnosed patients (35.2 kPa vs 6.4 kPa, P < .001). Accuracy for diagnosing cirrhosis at an LSM cut‐off ≥9.9 kPa was better in recently diagnosed (PPV: 74%, NPV: 100%) vs previously diagnosed (PPV: 53%, NPV: 82%) patients. Recently diagnosed patients had higher Area Under the Curve (AUC) for APRI (0.79 vs 0.61) and FIB‐4 (0.84 vs 0.65) than previously diagnosed patients. At APRI <1.5 and FIB‐4 <3.25 cirrhosis was ruled out with a specificity of 93% and 95% respectively. During a median follow‐up of 46 (24‐66) months, only 5.9% (5/85) of non‐cirrhotic WD patients showed progression to cirrhotic LSM values, while 30.8% (4/13) of cirrhotic WD patients showed LSM suggestive of cirrhosis regression. CONCLUSION: TE‐based LSM ≥9.9 kPa accurately identifies cirrhosis in WD patients. Next to TE‐LSM <9.9 kPa, APRI <1.5 and FIB‐4 <3.25 values assist to non‐invasively rule out cirrhosis. LSM remains stable in most non‐cirrhotic patients on WD therapy, while one‐third of cirrhotic patients present clinically relevant decreases in LSM. |
format | Online Article Text |
id | pubmed-7187206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71872062020-04-28 Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease Paternostro, Rafael Pfeiffenberger, Jan Ferenci, Peter Stättermayer, Albert F. Stauber, Rudolf E. Wrba, Fritz Longerich, Thomas Lackner, Karoline Trauner, Michael Ferlitsch, Arnulf Reiberger, Thomas Weiss, Karl Heinz Liver Int Genetics and Rare Liver Diseases BACKGROUND & AIMS: The value of liver stiffness measurement (LSM) by transient elastography (TE) for non‐invasive fibrosis staging and disease monitoring has not been established in patients with Wilson disease (WD). METHODS: Liver stiffness measurement by TE and non‐invasive fibrosis scores (APRI, FIB‐4) were analysed from 188 WD patients with liver biopsy (LBX). Longitudinal LSM was performed in 128 (68.1%) patients. RESULTS: One hundred and eighty‐eight patients (mean age: 35 ± 14 years, 54.8% women; 27.1% with histological cirrhosis) were studied. Forty‐four[23.4%] patients were recently diagnosed with WD, while 144[76.6%] were previously diagnosed (>1 year between LBX and LSM). Overall, LSM (11.3 vs 6.1 kPa, P < .001), APRI (0.72 vs 0.38, P < .001) and FIB‐4 (1.54 vs 0.89, P < .001) were higher in cirrhotic than in non‐cirrhotic patients. This was even more pronounced in recently diagnosed patients (35.2 kPa vs 6.4 kPa, P < .001). Accuracy for diagnosing cirrhosis at an LSM cut‐off ≥9.9 kPa was better in recently diagnosed (PPV: 74%, NPV: 100%) vs previously diagnosed (PPV: 53%, NPV: 82%) patients. Recently diagnosed patients had higher Area Under the Curve (AUC) for APRI (0.79 vs 0.61) and FIB‐4 (0.84 vs 0.65) than previously diagnosed patients. At APRI <1.5 and FIB‐4 <3.25 cirrhosis was ruled out with a specificity of 93% and 95% respectively. During a median follow‐up of 46 (24‐66) months, only 5.9% (5/85) of non‐cirrhotic WD patients showed progression to cirrhotic LSM values, while 30.8% (4/13) of cirrhotic WD patients showed LSM suggestive of cirrhosis regression. CONCLUSION: TE‐based LSM ≥9.9 kPa accurately identifies cirrhosis in WD patients. Next to TE‐LSM <9.9 kPa, APRI <1.5 and FIB‐4 <3.25 values assist to non‐invasively rule out cirrhosis. LSM remains stable in most non‐cirrhotic patients on WD therapy, while one‐third of cirrhotic patients present clinically relevant decreases in LSM. John Wiley and Sons Inc. 2020-01-22 2020-04 /pmc/articles/PMC7187206/ /pubmed/31898387 http://dx.doi.org/10.1111/liv.14368 Text en © 2020 The Authors. Liver International published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Genetics and Rare Liver Diseases Paternostro, Rafael Pfeiffenberger, Jan Ferenci, Peter Stättermayer, Albert F. Stauber, Rudolf E. Wrba, Fritz Longerich, Thomas Lackner, Karoline Trauner, Michael Ferlitsch, Arnulf Reiberger, Thomas Weiss, Karl Heinz Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease |
title | Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease |
title_full | Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease |
title_fullStr | Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease |
title_full_unstemmed | Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease |
title_short | Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease |
title_sort | non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with wilson disease |
topic | Genetics and Rare Liver Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187206/ https://www.ncbi.nlm.nih.gov/pubmed/31898387 http://dx.doi.org/10.1111/liv.14368 |
work_keys_str_mv | AT paternostrorafael noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease AT pfeiffenbergerjan noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease AT ferencipeter noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease AT stattermayeralbertf noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease AT stauberrudolfe noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease AT wrbafritz noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease AT longerichthomas noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease AT lacknerkaroline noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease AT traunermichael noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease AT ferlitscharnulf noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease AT reibergerthomas noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease AT weisskarlheinz noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease |